ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.475,45
0,12%
S&P 500
5.567,19
1,06%
Dow Jones
39.375,87
0,17%
Euro vs US Dollar
1,08505
0,37%
Bitcoin
56.636,98
-0,60%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Bellevue Life Sciences Acquisition Corporation (BLACU)

  7. Bellevue Life Sciences Acquisition Corporation (BLACU) News

BLACU

Bellevue Life Sciences A... (BLACU)

Bellevue Life Sciences Acquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BLACU
DatumZeitQuelleÜberschriftSymbolFirma
21/02/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
13/02/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
08/02/202422h20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
05/02/202419h48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/11/202323h00PR Newswire (US)OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/11/202322h37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/11/202322h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
15/11/202312h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
07/11/202322h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
20/10/202322h20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
10/10/202323h00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/08/202322h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/07/202322h58Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/07/202322h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
11/07/202322h45PR Newswire (US)Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business CombinationNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
28/06/202322h50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/06/202323h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
22/05/202322h35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
16/05/202314h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
31/03/202322h20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
27/03/202322h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
27/03/202322h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
27/03/202322h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/03/202321h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/03/202321h05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
28/02/202323h37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
23/02/202322h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
21/02/202322h05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment OptionNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
14/02/202322h05PR Newswire (US)Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public OfferingNASDAQ:BLACUBellevue Life Sciences Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BLACU

Kürzlich von Ihnen besucht

AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
DBI
TDXP
Tec DAX
NASDAQ
NVDA
NVIDIA
PM
XAUUSD
Gold vs US Dollar
CCOM
US100
US Tech 100
COIN
BTCUSD
Bitcoin
USOTC
BNPQY
BNP Paribas (QX)
DBI
MDAX
MDAX
NYSE
NKE
Nike
NYSE
DIS
Walt Disney
TG
BAYN
Bayer
NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten